Delta Financial Advisors LLC Novartis Ag Transaction History

Delta Financial Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$80.52 - $93.75 $20,532 - $23,906	-255 Reduced 2.57%	9,681 $818,000
Q3 2020 Oct 20, 2020	SELL	$82.14 - $91.0 $10,267 - $11,375	-125 Reduced 1.24%	9,936 $864,000
Q1 2020 Apr 27, 2020	SELL	$70.67 - $99.01 $27,561 - $38,613	-390 Reduced 3.73%	10,061 $830,000
Q4 2019 Feb 06, 2020	SELL	$84.35 - $95.37 $2,952 - $3,337	-35 Reduced 0.33%	10,451 $990,000
Q2 2019 Oct 11, 2019	BUY	$75.4 - $92.8 $790,644 - $973,100	10,486 New	10,486 $957,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Delta Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Delta Financial Advisors LLC with notifications on news.